Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Kwong, US
Andrew Kwong, Naperville, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20080244148 | VoIP Enabled Femtocell with a USB Transceiver Station - Telephone calls between a mobile station (MS) and the mobile network or PSTN are routed through the Internet via VoIP using a femtocell, as opposed to the traditional macrocellular network. The femtocell can comprise a USB Transceiver Station that is connected to a personal computer through a universal serial bus port, which provides both power and a multi-megabit per second connection between the personal computer and the USB transceiver station. The USB transceiver station can comprise a microcontroller to manage signaling between the RF front end/baseband processor and the personal computer, as well as a precise timing mechanism to assist the synchronization of femtocell timing with the surrounding macrocellular network, if it is present. The USB transceiver station can have a compact form factor that that facilitates a high degree of portability by the subscriber, such as being readily attachable to their keychain. | 10-02-2008 |
| 20120020293 | VOIP ENABLED FEMTOCELL WITH A USB TRANSCEIVER STATION - Telephone calls between a mobile station (MS) and the mobile network or PSTN are routed through the Internet via VoIP using a femtocell, as opposed to the traditional macrocellular network. The femtocell can comprise a USB Transceiver Station that is connected to a personal computer through a universal serial bus port, which provides both power and a multi-megabit per second connection between the personal computer and the USB transceiver station. The USB transceiver station can comprise a microcontroller to manage signaling between the RF front end/baseband processor and the personal computer, as well as a precise timing mechanism to assist the synchronization of femtocell timing with the surrounding macrocellular network, if it is present. The USB transceiver station can have a compact form factor that that facilitates a high degree of portability by the subscriber, such as being readily attachable to their keychain. | 01-26-2012 |
Andrew W. Kwong, Naperville, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20100290365 | MULTI-LEVEL HOSTED INBOUND ADMINISTRATION FOR A TELEPHONY SYSTEM - A multi-level hosted inbound administration platform for a packet-switched telephony system is provided. The platform provides services for managing the distribution and features of direct inward dialing numbers (DIDs). The platform allows a client to import or purchase DIDs, make DIDs available to sub-distributors, and provision them to end-users. The platform allows sub-distributors to reserve and activate DIDs, make DIDs available to downstream sub-distributors, and provision them to end-users. The platform provides a billing structure for DID usage, with charges being applied on a one-time, monthly, or variable basis. The platform also allows clients and sub-distributors to charge for inbound services based on per-minute or per-usage charges. | 11-18-2010 |
Ann Kwong, Cambridge, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20100172866 | Combination Therapy for the Treatment of HCV Infection - The present invention relates to therapeutic combinations comprising a protease inhibitor and a polymerase inhibitor for the treatment of HCV. The present invention also relates to therapeutic combinations comprising VX-950 and a polymerase inhibitor. Also within the scope of the invention are methods using the therapeutic combinations of the present invention for treating HCV infection or alleviating one or more symptoms thereof in a patient. The present invention also provides kits comprising the combinations of the present invention. | 07-08-2010 |
| 20110229874 | COMPOSITIONS AND METHODS USEFUL FOR HCV INFECTION - The present invention provides compositions comprising cells that can effectively produce HCV after HCV infection, compositions for culturing the cells, methods for making the composition and methods for infecting the cells in the composition with HCV. The present invention also provides methods for assaying HCV production and methods for evaluating compounds that affect the production of HCV. | 09-22-2011 |
| 20110244549 | HEPATITIS C VIRUS VARIANTS - The present invention relates to HCV variants, particularly variants that are resistant to a protease inhibitors such as VX-950. Also provided are methods and compositions related to the HCV variants. Further provided are methods of isolating, identifying, and characterizing multiple viral variants from a patient. | 10-06-2011 |
Ann D. Kwong, Cambridge, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20100189688 | Dose forms comprising VX-950 and their dosage regimen - The present invention relates to antiviral therapies and compositions for treating or preventing Hepatitis C infections in patients and relates to other methods disclosed herein. The invention also relates to kits and pharmaceutical packs comprising compositions and dosage forms. The invention also relates to processes for preparing these compositions, dosages, kits, and packs. | 07-29-2010 |
Ann Dak-Yee Kwong, Cambridge, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20120088904 | ANALYSIS OF HCV GENOTYPES - A method for predicting response of a patient infected with HCV-1a to interferon treatment | 04-12-2012 |
Arnold W. Kwong, Saint Paul, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20080219866 | Generation and Management of Mass Air Flow - Systems and methods for generating high velocity mass air flows are disclosed. High velocity mass air flow (air charging) devices are needed in a variety of research, industrial, commercial, and consumer applications. The exemplary systems and apparatus described incorporate an electric motor subassembly, an air effector subassembly, a highly intelligent apparatus controller subassembly (and interfaces), and linked sensors, connectors, and wiring. The exemplary method described includes the operational apparatus controller subassembly (e.g., elements, logic, and behavior) that controls the entire apparatus' functions and interactions. | 09-11-2008 |
Benedict Kwong, Dallas, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20100201633 | TOUCH SCREEN WITH IMPROVED OPTICAL PERFORMACE - An improved touch screen has enhanced optical performance and aesthetic quality. The sense electrodes and other traces on the touch screen are made less invisible to the user by substantially filling the space between the conductive traces or electrodes with isolated regions that match the light transmission characteristics of the electrodes. In capacitive and resistive touch screens, the space between ITO electrodes and other traces on the substrate is substantially filled with ITO to match the electrodes. The space between electrodes is preferably filled with isolated regions of ITO formed in a pattern. The isolated regions in the pattern may be shaped and the electrodes notched to create non-linear spaces to further reduce the visibility of the pattern. Further, the space between ITO traces can be filled with irregular-shaped ITO regions to further reduce the visibility of the space. | 08-12-2010 |
Cecil D. Kwong, Birmingham, AL US
| Patent application number | Description | Published |
|---|---|---|
| 20110286964 | AZO-SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS - The present invention provides compounds of Formula (I): (Chemical formula should be inserted here as it appears on abstract in paper form) (I) and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and prodrugs of said compounds, wherein each of R, R | 11-24-2011 |
| 20110286965 | ETHENYL-SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS - The present invention provides compounds of Formula (A): (Chemical formula should be inserted here as it appears on abstract in paper form) (A) and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and prodrugs of said compounds, wherein wherein each of R, R | 11-24-2011 |
| 20110318305 | SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS - The present invention provides compounds of Formula (I): and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and prodrugs of said compounds, wherein each of R, R | 12-29-2011 |
| 20120107271 | ETHYNYL-SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS - The present invention provides compounds of Formula (I): (Chemical formula should be inserted here as it appears on abstract in paper form) (I) and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and pro-drugs of said compounds, wherein each of R, R | 05-03-2012 |
Dim-Lee Kwong, Austin, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20080224236 | METAL GATE ELECTRODE FOR SEMICONDUCTOR DEVICES - A gate electrode for semiconductor devices, the gate electrode comprising a mixture of a metal having a work function of about 4 eV or less and a metal nitride. | 09-18-2008 |
| 20090163005 | Schottky barrier source/drain N-MOSFET using ytterbium silicide - A method of fabricating an N-type Schottky barrier Source/Drain Transistor (N-SSDT) with ytterbium silicide (YbSi | 06-25-2009 |
| 20090179281 | Schottky barrier source/drain N-MOSFET using ytterbium silicide - An N-type Schottky barrier Source/Drain Transistor (N-SSDT) that uses ytterbium silicide (YbSi | 07-16-2009 |
Elizabeth Kwong, Cranford, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110237541 | TRANSDERMALLY ADMINISTERED ALISKIREN - Dosage form of aliskiren, comprising a device for transdermal administration of aliskiren and aliskiren (including salts, prodrugs and metabolites thereof), optionally together with pharmaceutically acceptable carrier(s) to a human being or an animal in order to achieve a desired therapeutic effect. Use of a compound comprising aliskiren, optionally encompassing salts, prodrugs and metabolites thereof, and optionally together with pharmaceutically acceptable carrier(s), for the manufacture of a composition to be administered transdermally for achieving a desired therapeutic effect. Method for achieving a desired therapeutic effect by transdermal administration of a compound comprising aliskiren, optionally encompassing salts, prodrugs and metabolites thereof, and optionally together with pharmaceutically acceptable carrier(s). | 09-29-2011 |
Gabriel Kwong, Boston, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20100240050 | Methods and Products For In Vivo Enzyme Profiling - The present invention relates to methods and products associated with in vivo enzyme profiling. In particular, the invention relates to methods of in vivo processing of exogenous molecules followed by detection of signature molecules as representative of the presence of active enzymes associated with diseases or conditions. The invention also relates to products, kits, and databases for use in the methods of the invention. | 09-23-2010 |
Hank Kwong, Farmington Hills, MI US
| Patent application number | Description | Published |
|---|---|---|
| 20090275440 | VEHICLE RESPONSE DURING VEHICLE ACCELERATION CONDITIONS - A vehicle control method for transitioning through transmission lash regions is described using a variety of information, such as, for example, gear ratio, clutch slippage, etc. Further, different adjustment of spark and throttle angle is used to provide a rapid torque response while still reducing effects of the lash. Finally, transitions taking into account both slipping and non-slipping transmissions are described. | 11-05-2009 |
| 20110034298 | SYSTEM AND METHOD FOR IMPROVED VEHICLE RESPONSE DURING VEHICLE ACCELERATION CONDITIONS - A vehicle control method for a vehicle having an internal combustion engine coupled to a torque converter is described. In one embodiment, the engine air flow and spark are adjusted to control torque converter operation. The method can improve vehicle response to driver accelerator commands | 02-10-2011 |
Hung Kwong, Malta, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090131368 | MIXTURES OF AND METHODS OF USE FOR POLYUNSATURATED FATTY ACID-CONTAINING PHOSPHOLIPIDS AND ALKYL ETHER PHOSPHOLIPIDS SPECIES - A chemical composition of a molecular species mixture of phospholipids, purified to at least 85% purity through chromatography purification, the chemical composition contains enriched both sn-1-acyl fatty chains/sn-2-docosahexaenoic acid molecular species and sn-1-ether fatty chains/sn-2-docosahexaenoic acid molecular species, the phospholipids are selected from the group consisting of: phosphatidylcholine, phosphatidylserine and phosphatidylethanolamine. Methods using the above disclosed composition in mammals to treat various conditions. | 05-21-2009 |
Hung Kwong, San Antonio, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20110124061 | METHOD FOR PREPARATION OF POLYUNSATURATED FATTY ACID-CONTAINING PHOSPHATIDYLSERINE - A method for the preparation of the polyunsaturated fatty acids-containing phosphatidylserine, the method comprising: combining L-serine with a fish liver phosphatidylcholine having a polyunsaturated fatty acid to form a mixture; reacting the mixture with phospholipase D to effect transphosphatidylation of L-serine and the phosphatidylcholine having polyunsaturated fatty acids to produce the polyunsaturated fatty acids-containing phosphatidylserine. | 05-26-2011 |
Karric Kwong US
| Patent application number | Description | Published |
|---|---|---|
| 20080243366 | METHOD AND APPARATUS FOR DETECTING PRESENCE OF VEHICLE USING A MAGNETIC SENSOR EMPLOYING A MAGNETO-RESISTIVE EFFECT - Method using raw signal from magneto-resistive sensor through the use of recent variance (RV) of raw signal (RS) for first-capture of first time RV crosses variance detect, second-capture start enable for first time when RS crosses above raw detect and RV above variance detect, third-capture ending time when RS crosses below raw undetect and RV below variance undetect. Starting and ending times are products of the process, often used for traffic flow counts. Apparatus supporting this method as a processor and/or a vehicular sensor node. | 10-02-2008 |
Ka Yin Kwong, Gaithersburg, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20110150870 | FULLY HUMAN ANTI-HUMAN NKG2D MONOCLONAL ANTIBODIES - The invention relates to isolated fully human monoclonal antibodies having specificity for human NKG2D and compositions thereof. The invention further relates to methods for using such antibodies in treating diseases or conditions such as cancer, autoimmune disease, or infectious disease. | 06-23-2011 |
Kelvin Kwong, Tualatin, OR US
| Patent application number | Description | Published |
|---|---|---|
| 20110221841 | STRIPPING BLADE FOR STRIPPING MEDIA FROM A DRUM IN AN INKJET PRINTER - A stripper blade has been developed for high throughput inkjet printers. The stripper blade includes a metallic blade body having a first thickness that extends to a leading edge having a second thickness that is less than about 25% of the first thickness, and at least one beveled surface leading from the metallic blade body to the leading edge to form a stripping edge that facilitates separation of media from a drum. | 09-15-2011 |
Kennie Y. Kwong, Atlanta, GA US
| Patent application number | Description | Published |
|---|---|---|
| 20110176491 | OPTIMIZING STATIC DICTIONARY USAGE FOR SIGNAL COMPRESSION AND FOR HYPERTEXT TRANSFER PROTOCOL COMPRESSION IN A WIRELESS NETWORK - A method includes receiving a registration request including a first dictionary definition. The registration request is associated with user equipment. The method includes transmitting to the user equipment a response including a second dictionary definition. The method includes transmitting subsequent messages to the user equipment if the first and second dictionary definitions agree, the subsequent messages being compressed using the first static dictionary. | 07-21-2011 |
Manlik Kwong, Corvallis, OR US
| Patent application number | Description | Published |
|---|---|---|
| 20110184759 | QUALITY IMPROVEMENT (QI) REVIEW SYSTEM AND METHOD - A computer-implemented clinical quality review method involving: for each of a plurality of medical problem types, storing a corresponding set of review criteria; receiving a plurality of electronic patient care records (ePCRs) from a medical service provider (MSP), each ePCR identifying a patient treated by the MSP and information about the medical care provided to that patient by the MSP, including: clinical problem type, clinical impressions, symptoms, and details about the evaluation of and treatment provided to that patient by the MSP; and for each ePCR: (i) determining whether the medical care meets the set of review criteria associated with the medical problem type identified in that ePCR; (ii) if the medical care passes the set of review criteria, approving the medical care provided to that patient and forwarding information about the medical care provided to that patient to a reporting system; and (iii) if the medical care does not pass the set of review criteria, generating a notification indicating that a manual review of the medical care provided to that patient is required. | 07-28-2011 |
Peter Kwong, Wheeling, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20090104442 | Antimicrobial Gas Generating System - Gas generating and releasing articles consisting essentially of a polymer and a gas generating solid dispersed therein are described. The article generates a controlled fast and followed by a slow release gas in response to moisture. | 04-23-2009 |
Peter Kwong, Washington, DC US
| Patent application number | Description | Published |
|---|---|---|
| 20090191235 | CONFORMATIONALLY STABILIZED HIV ENVELOPE IMMUNOGENS AND TRIGGERING HIV-1 ENVELOPE TO REVEAL CRYPTIC V3-LOOP EPITOPES - Stabilized forms of gp120 polypeptide, nucleic acids encoding these stabilized forms, vectors comprising these nucleic acids, and methods of using these polypeptides, nucleic acids, vectors and host cells are disclosed. Crystal structures and computer systems including atomic coordinates for stabilized forms of gp120, and gp120 with an extended V3 loop, and methods of using these structures and computer systems are also disclosed. | 07-30-2009 |
| 20120034255 | CONFORMATIONALLY STABILIZED HIV ENVELOPE IMMUNOGENS - Stabilized forms of gp120 polypeptide, nucleic acids encoding these stabilized forms, vectors comprising these nucleic acids, and methods of using these polypeptides, nucleic acids, vectors and host cells are disclosed. Crystal structures and computer systems including atomic coordinates for stabilized forms of gp120, and gp120 with an extended V3 loop, and methods of using these structures and computer systems are also disclosed. | 02-09-2012 |
Peter D. Kwong, Washington, DC US
| Patent application number | Description | Published |
|---|---|---|
| 20090110690 | Hiv Gp120 Crystal Structure and Its Use to Identify Immunogens - The present disclosure relates to stabilized forms of the HIV gp120 envelope protein in complex with the broadly neutralizing CD4-binding site antibody b12, to crystalline forms of the stabilized forms of the HIV gp120 envelope protein in complex with the broadly neutralizing CD4-binding site antibody b12, and to the high resolution structure obtained from these crystals by X-ray diffraction methods. Methods for identifying immunogenic polypeptides based on these structures are also disclosed. | 04-30-2009 |
| 20090162390 | Molecular Scaffolds for HIV-1 Immunogens - Methods and compositions are provided which employ chimeric polypeptides having at least one heterologous epitope for a human immunodeficiency virus type 1 (HIV-1) neutralizing antibody. These chimeric polypeptides behave as molecular scaffolds which are capable of presenting the various heterologous HIV-1 epitopes. The invention demonstrates that a heterologous epitope recognized by the HIV-1 neutralizing antibody can be more fully exposed to neutralizing antibodies when presented within the backbone of the chimeric polypeptide than when the epitope is presented within the context of an HIV-1 backbone. Polynucleotides encoding these chimeric polypeptides are also provided. Immunogenic compositions are provided which comprise a chimeric polypeptide having at least one heterologous epitope that interacts with an HIV-1 neutralizing antibody. Immuno genie compositions comprising chimeric polynucleotides encoding the chimeric polypeptides of the invention are also provided. Vaccines comprising such immunogenic compositions are also provided. Further provided are methods which employ the immunogenic compositions of the invention. Such methods include, for example, methods for eliciting an immune response in a subject, methods for generating antibodies specific for the chimeric polypeptide or the chimeric polypeptide, and methods for inhibiting or preventing infection by HIV-1 in a subject. | 06-25-2009 |
| 20090220536 | HIV vaccine immunogens and immunization strategies to elicit broadly-neutralizing anti-HIV-1 antibodies against the membrane proximal domain of HIV GP41 - This invention relates to novel peptide immunogens that generate an immune response in mammals against HIV gp41, to pharmaceutical compositions that comprise such immunogens, and to methods of treating Immunodeficiency disease, especially HIV infection and AIDS, that employ such pharmaceutical compositions. | 09-03-2009 |
| 20100068217 | EPITOPE-TRANSPLANT SCAFFOLDS AND THEIR USE - Computational protocols for the design of epitope-protein scaffolds which elicit selected neutralizing antibodies are disclosed, and related compositions and uses. | 03-18-2010 |
| 20120034254 | ANTIGENIC CLOAKING AND ITS USE - Disclosed are antigens that include a target epitope that is defined by atomic coordinates of those amino acids of the antigen that contact an antibody of interest that specifically binds the antigen. The disclosed antigens have between about 10% and about 90% of surface exposed amino acid residues located exterior of the target epitope substituted as compared to a wild-type antigen and less than about 10% of the non-surface exposed amino acid residues substituted as compared to a wild-type antigen. Also disclosed are nucleic acids encoding these antigens and methods of producing these antigens. Methods for generating an immune response in a subject are also disclosed. In some embodiments, the method is a method for treating or preventing a human immunodeficiency type 1 (HIV-1) infection in a subject. | 02-09-2012 |
Ranee W. Kwong, Wappingers Falls, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110291284 | INTERCONNECT STRUCTURE WITH AN OXYGEN-DOPED SiC ANTIREFLECTIVE COATING AND METHOD OF FABRICATION - An interconnect structure is provided that includes at least one patterned and cured photo-patternable low k material located on a surface of a patterned and cured oxygen-doped SiC antireflective coating (ARC). A conductively filled region is located within the at least one patterned and cured photo-patternable low k material and the patterned and cured oxygen-doped SiC ARC. The oxygen-doped SiC ARC, which is a thin layer (i.e., less than 400 angstroms), does not produce standing waves that may degrade the diffusion barrier and the electrically conductive feature that are embedded within the patterned and cured photo-patternable low k dielectric material and, as such, structural integrity is maintained. Furthermore, since a thin oxygen-doped SiC ARC is employed, the plasma etch process time used to open the material stack of the ARC/dielectric cap can be reduced, thus reducing potential plasma damage to the patterned and cured photo-patternable low k material. Also, the oxygen-doped SiC ARC can withstand current BEOL processing conditions. | 12-01-2011 |
Ranee Wai-Ling Kwong, Hopewell Junction, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110101507 | METHOD AND STRUCTURE FOR REWORKING ANTIREFLECTIVE COATING OVER SEMICONDUCTOR SUBSTRATE - A method and a structure for reworking an antireflective coating (ARC) layer over a semiconductor substrate. The method includes providing a substrate having a material layer, forming a planarization layer on the material layer, forming an organic solvent soluble layer on the planarization layer, forming an ARC layer on the organic solvent soluble layer, forming a pattern in the ARC layer, and removing the organic solvent soluble layer and the ARC layer with an organic solvent while leaving the planarization layer unremoved. The structure includes a substrate having a material layer, a planarization layer on the material layer, an organic solvent soluble layer on the planarization layer, and an ARC layer on the organic solvent soluble layer. | 05-05-2011 |
Ranee Wai-Ling Kwong, Wappingers Falls, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20080248208 | APPARATUS AND METHOD FOR MEASURING THE QUANTITY OF CONDENSABLE MATERIALS WHICH OUTGAS DURING CURE OF ORGANIC THIN FILMS - An apparatus and method for measuring an amount of condensable material which outgas during cure of organic thin films. The apparatus includes a hotplate placed in a chamber having a removeable liner and means for cooling the liner. The method includes: weighing the liner, sequentially placing multiple substrates on said hotplate, and then weighing the liner again. | 10-09-2008 |
| 20090176174 | MULTIPLE EXPOSURE PHOTOLITHOGRAPHY METHODS AND PHOTORESIST COMPOSTIONS - A method and a composition. The composition includes a polymer and a photosensitive acid generator capable of generating a first amount of acid upon exposure to a first dose of radiation and a second amount of acid upon exposure to a second dose of radiation. The second amount of acid is greater than said first amount of acid. The second dose is greater than the first dose. The composition includes a photosensitive base generator capable of generating a first amount of base upon exposure to the first dose and a second amount of base upon exposure to the second dose, where the first amount of base is greater than the first amount of acid and the second amount of base is less than the second amount of acid. A method for exposing to radiation a film of a photoresist on a substrate is included. | 07-09-2009 |
| 20090214959 | PHOTORESIST COMPOSITIONS AND METHODS RELATED TO NEAR FIELD MASKS - A structure and a photolithography method. The method includes forming a first layer of a first photoresist including a first polymer and a first photosensitive acid generator. A second layer of a second photoresist, including a second polymer having at least one phenyl or phenolic moiety, is formed directly onto the first layer. The second layer is patternwise imaged, resulting in exposing at least one first portion. The first portion is removed, revealing at least one first region of the first layer. A second portion of the second layer remains forming a structure having opaque regions. The structure and first region are exposed. The opaque regions shield from radiation at least one second region of the first layer, resulting in producing acid in the first region and in the structure. The structure and base-soluble regions of the first layer are removed. A structure is also described. | 08-27-2009 |
| 20090214981 | PHOTORESISTS AND METHODS FOR OPTICAL PROXIMITY CORRECTION - Photolithography compositions and methods. A first layer of a first photoresist is formed on a substrate. A second layer of a second photoresist is formed directly onto the first layer. The second polymer of the second photoresist includes an absorbing moiety. The second layer is patternwise imaged and developed, resulting in removal of base-soluble regions. A relief pattern from the second layer remains. The relief pattern and the first layer are exposed to a second dose of the radiation. The polymer in the relief pattern absorbs a portion of the second dose. A fraction of the second dose passes through the at least one region of the relief pattern and exposes at least one region of the first layer. The relief pattern and base-soluble regions of the first layer are removed. A relief pattern from the first layer remains. A second photolithography method and a photoresist composition are also included. | 08-27-2009 |
| 20090291392 | WET DEVELOPABLE BOTTOM ANTIREFLECTIVE COATING COMPOSITION AND METHOD FOR USE THEREOF - The present invention discloses an antireflective coating composition for applying between a substrate surface and a positive photoresist composition. The antireflective coating composition is developable in an aqueous alkaline developer. The antireflective coating composition comprises a polymer, which comprises at least one monomer unit containing one or more moieties selected from the group consisting of a lactone, maleimide, and an N-alkyl maleimide; and at least one monomer unit containing one or more absorbing moieties. The polymer does not comprise an acid labile group. The present invention also discloses a method of forming and transferring a relief image by using the inventive antireflective coating composition in photolithography. | 11-26-2009 |
Raymond C. Kwong, Plainsboro, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100289406 | 2-AZATRIPHENYLENE MATERIALS FOR ORGANIC LIGHT EMITTING DIODES - Compounds containing 2-azatriphenylene are provided. In particular, compounds containing a 2-azatriphenylene core having an additional aromatic group are provided. The compounds provided may be emissive or non-emissive materials. The compounds may be used in organic light emitting devices, particularly as host materials, hole blocking layer materials, or emitting dopants. Devices comprising 2-azatriphenylene containing compounds may demonstrate improved stability and efficiency. | 11-18-2010 |
| 20110278556 | Azaborinine Compounds As Host Materials And Dopants For PHOLEDs - Novel organic compounds comprising azaborine are provided. In particular, the compounds comprise a dibenzo-1,4,-azaborine core having a phenyl substituent on the boron atom, and aryl or heteroaryl substituents at positions 2 and 6 of the phenyl substituent. These compounds may be advantageously used in organic light-emitting devices to provide improved efficiency and lifetime. | 11-17-2011 |
| 20110279019 | AZABORININE COMPOUNDS AS HOST MATERIALS AND DOPANTS FOR PHOLEDS - Novel organic compounds comprising azaborine are provided. In particular, the compounds comprise a dibenzo-1,4,-azaborine core having a phenyl substituent on the boron atom, and aryl or heteroaryl substituents at positions 2 and 6 of the phenyl substituent. These compounds may be advantageously used in organic light-emitting devices to provide improved efficiency and lifetime. | 11-17-2011 |
| 20110304262 | Delayed-Fluorescence OLED - Novel organic compounds comprising a substituted anthracene or acridine ligand are provided. In particular, the compound includes an anthracene ligand substituted at the 9 and 10 positions. The compound may be used in organic light emitting devices to provide devices having improved efficiency and lifetime. In particular, these compounds may be especially beneficial for use in blue-emitting OLEDs. | 12-15-2011 |
Samuel Kwong, Bellevue, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20110112418 | ECG MONITORING SYSTEM WITH CONFIGURABLE ALARM LIMITS - An ECG monitoring system for ambulatory patients includes a small multi-electrode patch that adhesively attaches to the chest of a patient. A reusable battery-powered ECG monitor clips onto the patch and receives patient electrical signals from the electrodes of the patch. A processor continuously processes received ECG signals and analyzes the received ECG signals for pre-defined arrhythmia. If an arrhythmia is detected, a wireless transceiver in the ECG monitor transmits the event information and an ECG strip to a monitoring center. At the commencement of a monitoring procedure a message is sent to the monitoring center and configuration information for arrhythmia detection is down-loaded and installed in the monitor. The configuration file is determined by a screen of selectable standard and custom arrhythmias and alarm limits at the monitoring center. | 05-12-2011 |
| 20110125040 | WIRELESS ECG MONITORING SYSTEM - An ECG monitoring system for ambulatory patients includes a reusable battery-powered ECG monitor with an electrode attached to a patient for receiving ECG signals. A processor analyzes the received ECG signals for predefined arrhythmia. If an arrhythmia is detected, a wireless transceiver in the ECG monitor transmits the event information and an ECG strip to a cellphone handset. The cellphone handset automatically relays the event information and ECG strip to a monitoring center for further diagnosis and necessary intervention. The ECG monitor sends notifications to the cellphone handset whenever the status of the monitor changes. The cellphone handset forwards status notifications to which a patient response has not been received to the monitoring center, as well as status notifications generated by the cellphone handset. | 05-26-2011 |
Tony C. Kwong, Cary, NC US
| Patent application number | Description | Published |
|---|---|---|
| 20080235196 | Confidential Content Search Engine - A security compliance search engine is provided for searching one or more client computing devices for items of information that meet a security criteria identifying items of information containing confidential content. Results of the search are provided to an analysis engine for determining if the items of information identified by the search are being maintained in accordance with a security policy for ensuring the confidentiality of the confidential content. Results of the analysis may be used to generate a report or log and to generate a notification to the client computing device identifying any violations of the security policy and possible solutions for bringing the item of information into compliance with the security policy. In addition, an administrator may be notified of any violations so that corrective action may be taken. | 09-25-2008 |
| 20080235760 | Confidential Content Reporting System and Method with Electronic Mail Verification Functionality - A confidential content reporting system and method with electronic mail verification functionality are provided. With the system and method, a security compliance search engine is provided for searching items of information to identify items containing confidential content and security violations with regard to this confidential content. Results of the search may be reported to a user via a graphical user interface (GUI) that identifies the item of information, the security violations detected, and suggested corrective actions, such as encryption. A user may interact with the GUI to apply security mechanisms in accordance with the suggested corrective actions. Moreover, the searching and reporting mechanism may be used to search electronic mail messages and their attachments prior to distribution of the electronic mail messages. Automatic modification of the electronic mail message to modify distribution lists and/or content of the electronic mail message may be performed using the mechanisms of the illustrative embodiments. | 09-25-2008 |
Yat Wai Edwin Kwong US
| Patent application number | Description | Published |
|---|---|---|
| 20120110094 | ELECTRONIC MESSAGING SYSTEMS SUPPORTING PROVISION OF ENTIRE FORWARDING HISTORY REGARDING THE SENDING, RECEIVING, AND TIME ZONE INFORMATION, OF AN EMAIL AFTER THE EMAIL IS FORWARDED BY A NUMBER OF USERS - Systems and methods are provided for supporting provision of forwarding history of email information. In accordance with one implementation, a system is provided that includes supporting provisioning of entire forwarding history regarding the sending and receiving time zone information, of an email after the email has been forwarded by a number of users. The system is further configured to send, by the email sender, an email to the email receiver, through a email incoming server. Further, the system allows users to compose outgoing emails to another email receiver. In addition, the system includes sending the outgoing email, by the email receiver, to the other email receiver through a SMTP server. | 05-03-2012 |